GoPath Laboratories is a state-of-the-art CAP-accredited, CLIA-certified molecular diagnostic laboratory providing anatomic pathology, hematopathology, and hereditary cancer testing for clinicians, hospital systems, and pharmaceutical firms. Located just north of Chicago, our laboratory incorporates the latest technologies into our testing platforms including next-generation sequencing, cytogenetics, FISH, IHC, microarray analysis, and ddPCR. We specialize in cancer diagnostics through our OncoTarget NGS testing series, which includes solid tumor and liquid biopsy analysis to detect and monitor a cancers genetic mutations. We also offer a wide-range of hereditary cancer testing through our GeneticsNow platform including BRCANow for familial breast, ovarian and prostate cancer and LynchNow for the hard-to-detect Lynch syndrome.
GoPath Exhibits at ASCO 2017 Annual MeetingDETAILS
New Test Release: OncoTarget for Solid TumorDETAILS
GoPath Launches Mobile AppDETAILS
GoPath Participates in #RedNoseDayDETAILS
GoPath Celebrates #LabWeek 2017DETAILS
GoPath Set to Exhibit at #ASCO17DETAILS